Leuven (Belgium), September 9, 2019 – Materialise, a global leader in 3D printing solutions, has extended its 3D printing materials offering with the new Ultrasint TPU 01. TPU is a fully-functional, flexible material, making it ideal for resistant and elastic parts. Today, Materialise is the first to make the new material available through its online platforms Materialise OnSite and i.materalise, and through its offline prototyping and manufacturing services.
Executive Chairman Peter Leys commented, “In spite of a macro-economic environment that continues to be challenging, Materialise reported another quarter of top-line growth. This was mainly driven by Materialise Medical, which continued to perform strongly with solid revenue growth and EBITDA performance, and also by Materialise Manufacturing, which realized a double-digit EBITDA margin and grew its revenues for the third consecutive quarter.
This quarter, the contribution by Materialise Software to our revenue growth and Adjusted EBITDA margin was below our expectations as a number of sales were pushed out to the second half of the year. Our outlook for 2019 remains within our previous guidance range, with our results now including expected contributions from our August acquisition of a 75% stake in Engimplan. This investment, which will enable us to introduce the benefits of Materialise’s patient-specific 3D printing implants and expertise to the fast-growing Brazil market, is part of our strategy to accelerate our growing presence in the additive manufacturing ecosystem through carefully selected acquisitions and partnerships.”
Leuven, Belgium / Rio Claro, Brazil – August 1, 2019. Materialise, a global leader in 3D printing solutions, today announced a strategic investment in Engimplan, a Brazil-based manufacturer of orthopedic and cranio-maxillofacial (CMF) implants and instruments. The combination of Materialise’s expertise in 3D printed medical solutions with Engimplan’s innovative product portfolio will help to accelerate the introduction of 3D printed, personalized implants and instruments in the Brazilian market.
CHICAGO (TVT2019 – Structural Heart Summit), June 13, 2019 – Materialise, a global 3D printing software and solutions company, has received FDA clearance for its Mimics Enlight cardiovascular planning software suite. The first release will support clinicians planning complex transcatheter mitral valve replacement (TMVR) procedures.
Detroit (USA) - May 20. Materialise NV (Nasdaq: MTLS), a global leader in 3D printing solutions, has partnered with HP, Nikon and Essentium to bring improved productivity and connectivity to additive manufacturing operations. The partnerships, announced during the 2019 RAPID+TCT Conference in Detroit, will support the adoption of 3D printing by industrial manufacturers. Materialise also announced that it will release a new version of its 3D printing operations management software, Streamics 8 in June 2019.